Susquehanna International Group
CDMO

Susquehanna International Group’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Susquehanna International Group’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-48,131
Closed -$594K – 13776
2024
Q4 		$594K Buy
48,131
+3,234
+7% +$37K ﹤0.01% 8249
2024
Q3 		$511K Sell
44,897
-3,106
-6% -$31.2K ﹤0.01% 8416
2024
Q2 		$343K Sell
48,003
-43,272
-47% -$331K ﹤0.01% 9155
2024
Q1 		$612K Sell
91,275
-90,932
-50% -$626K ﹤0.01% 8029
2023
Q4 		$1.18M Buy
182,207
+136,157
+296% +$878K ﹤0.01% 6575
2023
Q3 		$435K Buy
46,050
+21,308
+86% +$256K ﹤0.01% 8562
2023
Q2 		$346K Sell
24,742
-314,051
-93% -$5.35M ﹤0.01% 9155
2023
Q1 		$6.36M Buy
338,793
+313,881
+1,260% +$5.16M ﹤0.01% 3097
2022
Q4 		$343K Sell
24,912
-42,036
-63% -$644K ﹤0.01% 8774
2022
Q3 		$1.28M Buy
66,948
+44,720
+201% +$815K ﹤0.01% 5998
2022
Q2 		$339K Sell
22,228
-46,751
-68% -$691K ﹤0.01% 9242
2022
Q1 		$1.41M Sell
68,979
-2,172
-3% -$44.2K ﹤0.01% 6306
2021
Q4 		$2.08M Sell
71,151
-10,305
-13% -$295K ﹤0.01% 5409
2021
Q3 		$1.76M Buy
81,456
+35,671
+78% +$861K ﹤0.01% 6126
2021
Q2 		$1.17M Buy
45,785
+26,648
+139% +$569K ﹤0.01% 7310
2021
Q1 		$349K Sell
19,137
-11,654
-38% -$194K ﹤0.01% 10300
2020
Q4 		$355K Sell
30,791
-17,676
-36% -$162K ﹤0.01% 8944
2020
Q3 		$369K Buy
48,467
+6,894
+17% +$52.2K ﹤0.01% 8300
2020
Q2 		$273K Sell
41,573
-3,087
-7% -$17.2K ﹤0.01% 8514
2020
Q1 		$228K Sell
44,660
-9,668
-18% -$58.5K ﹤0.01% 8466
2019
Q4 		$417K Sell
54,328
-76,767
-59% -$448K ﹤0.01% 7336
2019
Q3 		$695K Buy
131,095
+19,883
+18% +$123K ﹤0.01% 6541
2019
Q2 		$623K Buy
111,212
+55,145
+98% +$227K ﹤0.01% 6798
2019
Q1 		$238K Buy
+56,067
New +$229K ﹤0.01% 7609
2018
Q2 		– Sell
-57,882
Closed -$201K – 10580
2018
Q1 		$169K Buy
57,882
+25,684
+80% +$79.3K ﹤0.01% 8450
2017
Q4 		$125K Buy
+32,198
New +$138K ﹤0.01% 8600
2017
Q3 		– Sell
-15,090
Closed -$56.7K – 9776
2017
Q2 		$64K Buy
+15,090
New +$61.8K ﹤0.01% 8836
2017
Q1 		– Sell
-10,202
Closed -$34.2K – 10173
2016
Q4 		$22K Buy
+10,202
New +$23.8K ﹤0.01% 9421
2016
Q2 		– Sell
-11,685
Closed -$32.6K – 9475
2016
Q1 		$34K Buy
11,685
+2,915
+33% +$15.6K ﹤0.01% 8741
2015
Q4 		$72K Sell
8,770
-11,334
-56% -$91.5K ﹤0.01% 9005
2015
Q3 		$144K Buy
20,104
+154
+0.8% +$1.28K ﹤0.01% 8952
2015
Q2 		$183K Buy
19,950
+3,847
+24% +$37K ﹤0.01% 9354
2015
Q1 		$152K Sell
16,103
-11,423
-41% -$110K ﹤0.01% 8801
2014
Q4 		$268K Buy
27,526
+612
+2% +$6.16K ﹤0.01% 8322
2014
Q3 		$256K Sell
26,914
-21,261
-44% -$238K ﹤0.01% 8272
2014
Q2 		$634K Sell
48,175
-1,886
-4% -$23.8K ﹤0.01% 7016
2014
Q1 		$666K Buy
50,061
+38,930
+350% +$513K ﹤0.01% 6243
2013
Q4 		$108K Sell
11,131
-1,751
-14% -$16.5K ﹤0.01% 8609
2013
Q3 		$127K Sell
12,882
-36,397
-74% -$362K ﹤0.01% 7990
2013
Q2 		$444K Buy
+49,279
New +$516K ﹤0.01% 6226

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Susquehanna International Group's CDMO Position: Q1 2025 in Review

Susquehanna International Group sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 48,131 shares — an estimated $594K sold.

Susquehanna International Group first reported a position in CDMO in Q2 2013 and held it in 40 quarters. The position peaked at $6.36M in Q1 2023. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Susquehanna International Group reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Susquehanna International Group sold 48,131 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $594K.
  • Susquehanna International Group first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 40 quarters.
  • Susquehanna International Group's Avid Bioservices, Inc. Common Stock position peaked at $6.36M in Q1 2023.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.